SoftBank Group Reports Profit Beat, Boosted by Intel Stake

The Japanese technology investment company's bottom line was boosted by a surge in the value of its stake in Intel.

Deal or No Deal, AstraZeneca Stock Is a Bargain

The logic of a pharma megamerger is questionable, but AstraZeneca's record isn't.

Siemens Shares Fall as Digital Industries Order Growth Misses Expectations